Vilin Bio Med Limited — Updates, 30-03-2026: General Updates
30-03-2026 | 11:50 am
30-03-2026 | 11:50 am
Vilin Bio Med secured in-principle NSE approval to list 1.3 Cr new equity shares (Rs.10 face value) allotted through a preferential issue. This move enhances share float and market access for these shares.
No comments yet. Be the first to comment!
